With optimistic projections of a COVID-19 vaccine on the horizon sometime in late 2020 or early 2021 (see: Pfizer and Moderna beginning Phase 3 trials and Oxford’s ‘so-far’ successful trials) there is another factor often not talked about in the fight against COVID-19.
We might be tackling the biological issue with the development of vaccines, but the societal issues of actually administering and distributing the vaccine are yet to be widely
...